Barclays PLC Sanara Med Tech Inc. Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Barclays PLC holds 2,699 shares of SMTI stock, worth $76,165. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,699
Previous 5,336
49.42%
Holding current value
$76,165
Previous $220,000
54.55%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SMTI
# of Institutions
44Shares Held
690KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY198KShares$5.58 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA144KShares$4.07 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA79.3KShares$2.24 Million0.0% of portfolio
-
State Street Corp Boston, MA53.5KShares$1.51 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL30.7KShares$865,6760.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $234M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...